Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [F]DOPA PET Study. (2017)

First Author: Kim E
Attributed to:  PET Methodology funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/npp.2016.258

PubMed Identifier: 27857125

Publication URI: http://europepmc.org/abstract/MED/27857125

Type: Journal Article/Review

Volume: 42

Parent Publication: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Issue: 4

ISSN: 0893-133X